Page last updated: 2024-08-23

pergolide and Nerve Degeneration

pergolide has been researched along with Nerve Degeneration in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergmans, P; Booij, J; Stoof, JC; van Royen, EA; Winogrodzka, A; Wolters, EC1
Clow, A; Glover, V; Sandler, M1

Reviews

1 review(s) available for pergolide and Nerve Degeneration

ArticleYear
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
    Journal of neural transmission. Supplementum, 1993, Volume: 40

    Topics: Aging; Animals; Corpus Striatum; Enzyme Induction; Free Radicals; Humans; Isatin; Life Expectancy; Nerve Degeneration; Parkinson Disease; Pergolide; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase

1993

Trials

1 trial(s) available for pergolide and Nerve Degeneration

ArticleYear
Pergolide and selegiline for Parkinson's disease.
    The Medical letter on drugs and therapeutics, 1989, Sep-08, Volume: 31, Issue:800

    Topics: Animals; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Pergolide; Phenethylamines; Selegiline

1989

Other Studies

1 other study(ies) available for pergolide and Nerve Degeneration

ArticleYear
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2003, Volume: 74, Issue:3

    Topics: Antiparkinson Agents; Benzothiazoles; Caudate Nucleus; Cocaine; Corpus Striatum; Disease Progression; Female; Humans; Male; Nerve Degeneration; Parkinson Disease; Pergolide; Pramipexole; Putamen; Radiopharmaceuticals; Receptors, Dopamine D2; Reproducibility of Results; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2003